Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascularization”

578 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 578 results

Not applicableActive Not RecruitingNCT05152524
What this trial is testing

Distal Ischemic Stroke Treatment With Adjustable Low-profile Stentriever

Who this might be right for
Ischemic StrokeNeovascularization
Rapid Medical 168
Early research (Phase 1)Study completedNCT01968486
What this trial is testing

Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia

Who this might be right for
Myopia, Degenerative
University of Campania Luigi Vanvitelli 60
Early research (Phase 1)Ended earlyNCT01334255
What this trial is testing

ISONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Degeneration (AMD) or Polypoidal Choroidal Vasculopathy (PCV)

Who this might be right for
Pigment Epithelial Detachment
Lpath, Inc. 12
Large-scale testing (Phase 3)Study completedNCT00000153
What this trial is testing

Krypton-Argon Regression of Neovascularization Study (KARNS)

Who this might be right for
Diabetic RetinopathyRetinal NeovascularizationDiabetes Mellitus
National Eye Institute (NEI)
Large-scale testing (Phase 3)Study completedNCT00370786
What this trial is testing

Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)

Who this might be right for
Choroidal Neovascularization
Shahid Beheshti University of Medical Sciences 31
Large-scale testing (Phase 3)Study completedNCT00436553
What this trial is testing

Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization

Who this might be right for
Macular DegenerationChoroidal Neovascularization
Novartis 321
Not applicableStudy completedNCT04650672
What this trial is testing

Daily Testing at Home by NV-AMD Subjects With Notal Home OCT.

Who this might be right for
Retinal Neovascularization
Notal Vision Inc. 15
Testing effectiveness (Phase 2)Study completedNCT00511875
What this trial is testing

Evaluation of Doxycycline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Thomas Gardner 30
Not applicableUnknownNCT00383812
What this trial is testing

Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy

Who this might be right for
Polypoidal Choroidal Vasculopathy
Asan Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT00259753
What this trial is testing

Safety and Efficacy Study of Small Interfering Ribonucleic Acid (RNA) Molecule (Cand5) to Treat Wet Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
OPKO Health, Inc. 120
Large-scale testing (Phase 3)Study completedNCT00545870
What this trial is testing

Bevacizumab Versus Ranibizumab for Diabetic Retinopathy

Who this might be right for
Diabetic RetinopathyDiabetic Macular EdemaProliferative Diabetic Retinopathy
Ursula Schmidt-Erfurth, M.D. 30
Large-scale testing (Phase 3)Looking for participantsNCT07389980
What this trial is testing

Prospective Trial of the Efficacy and Safety of a Personalized Regimen of High-dose Aflibercept 8mg on Treatment-naive Polypoidal Choroidal Vasculopathy: the PALLAS Trial

Who this might be right for
Polypoidal Choroidal VasculopathyPolypoidal Choroidal Vasculopathy (PCV)
Yeungnam University College of Medicine 50
Post-approval studies (Phase 4)UnknownNCT04380974
What this trial is testing

Efficacy and Safety of Two Regimens of Anti-VEGF Therapy in Chinese Patients With Polypoidal Choroidal Vasculopathy

Who this might be right for
Polypoidal Choroidal Vasculopathy
Xiaodong Sun 102
Large-scale testing (Phase 3)Study completedNCT04264819
What this trial is testing

Study of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 295
Testing effectiveness (Phase 2)Study completedNCT00510965
What this trial is testing

Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE)

Who this might be right for
Choroidal Neovascularization
University Hospital, Bonn 10
Testing effectiveness (Phase 2)Study completedNCT01445899
What this trial is testing

PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)

Who this might be right for
Choroidal NeovascularizationDiabetic RetinopathyDiabetic Macular Edema
Quark Pharmaceuticals 258
Not applicableNot Yet RecruitingNCT06918028
What this trial is testing

An Interpretable Fundus Diseases Report Generating System Based On Weakly Labelings

Who this might be right for
Retinal DiseasesChoroidal DiseasePathological Myopia+3 more
Zhongshan Ophthalmic Center, Sun Yat-sen University 9,999
Early research (Phase 1)Study completedNCT00749021
What this trial is testing

Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments

Who this might be right for
Retinal Pigment Epithelial Detachment
Clement K. Chan 40
Testing effectiveness (Phase 2)Study completedNCT02504944
What this trial is testing

Safety and Efficacy of Propranolol 0.2% Eye Drops in Treating Retinopathy of Premature: A Pilot Study (DROP-ROP-0.2%)

Who this might be right for
Retinopathy of Prematurity
Meyer Children's Hospital IRCCS 98
Testing effectiveness (Phase 2)Study completedNCT00304954
What this trial is testing

Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationChoroidal Neovascularization
National Eye Institute (NEI) 13
Load More Results